FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Similar Posts
Psychiatry operates within a pre-Copernican framework of science
Dr. E. Jane Costello, a professor of psychiatry and behavioral sciences at Duke University, acknowledges: “The system of diagnosis is still 200 to 300 years behind other branches of medicine.” Psychiatry also fails to be guided by an evidence-based positive benefit / risk assessment of its prescribed treatments.
Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT
The New York Times reports that internal marketing documents show that “Eli Lilly encouraged primary care physicians to use Zyprexa, in patients who did not have either condition.”
DANGEROUS DRUG LICENSING GAME THE FDA PLAYS
DANGEROUS DRUG LICENSING GAME THE FDA PLAYS Thu, 6 Mar 2003 In her column on Red Flags Weekly, Dr. Meryl Nass describes how the FDA in concert with the Justice Department have been lowering the bar for safety of drugs and vaccines used on military personnel. The significance is that…
Drug Companies are Outsourcing Drug Trials – WP
Drug Companies are Outsourcing Drug Trials – WP Wed, 4 May 2005 The Washington Post reports that a study by Tufts has found a drop in the number of pharmaceutical company sponsored drug trials. Fewer new drug applications are being submitted to the FDA, and there has been a drop…
VACCINE EPIDEMIC
Vaccines are legally classified as "unavoidably unsafe"–an indication that they pose an inherent risk. Vaccines have not been subjected to scientifically rigorous placebo controlled safety trials before they have been approved for use in children. The public debate over vaccine safety has intensified as a continuing stream of news reports…
FDA reviews depression drugs–Intense or Cautious? WashPost/ NYT/ Herald
FDA reviews depression drugs–Intense or Cautious? WashPost/ NYT/ Herald Wed, 29 Oct 2003 The Washington Post correctly reports: “The association between antidepressants, particularly the selective serotonin reuptake inhibitors (SSRIs), and suicide has been controversial since the first SSRI, Prozac, came on the market in the late 1980s.” But stakeholders in…